The Assisi Think Tank Meeting and Survey of post MAstectomy Radiation Therapy after breast reconstruction: The ATTM-SMART report

Cynthia Aristei, Orit Kaidar-Person, Luca Tagliaferri, Meritxell Arenas, Charlotte E. Coles, Birgitte V. Offersen, Giovanni Frezza, Maria Cristina Leonardi, Vincenzo Valentini, Céline Bourgier, Philip M.P. Poortmans

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Purpose: To describe the current European practise on post-mastectomy radiation therapy (PMRT) in relation to breast reconstruction. Methods: A 21-item questionnaire was distributed online via Survey Monkey. Items referred to 1. general topics (country, centre, years of experience in breast cancer); 2. clinical decision making; 3. RT techniques and dosimetry; 4. dose fractionation. Results: 283 responses were received from 19 countries. Most responders worked in public health services and in academic institutions and had 5–20 years experience. Although many indicated they were consulted about the timing and type of breast reconstructive surgery, final decisions were most often made by surgeons. Immediate reconstruction with expander followed by RT and subsequently permanent reconstruction with prosthesis was recommended by 61.6% of responders. Most (48.4%) adviced a boost only when margins were close or involved with an another 17.7% recommending it in the presence of high-risk features (T3-T4, lympho-vascular involvement). Intensity modulated RT was rarely used by about two-thirds of responders, except when with 3D technique the dose constraints were not achieved or when regional lymph nodes were included. Almost 60% of responders did not use bolus/tissue equivalent material (TEM). The main indication for bolus/TEM use was skin involvement. The majority of responders used 1.8–2 Gy per fraction. Conclusions: The present survey highlighted controversial areas in clinical practise, confirming the uncertainties about the scheduling of PMRT and breast reconstruction.

Original languageEnglish
Pages (from-to)436-443
Number of pages8
JournalEuropean Journal of Surgical Oncology
Volume44
Issue number4
DOIs
Publication statusPublished - Apr 1 2018

Fingerprint

Mammaplasty
Mastectomy
Radiotherapy
Reconstructive Surgical Procedures
Dose Fractionation
United States Public Health Service
Prostheses and Implants
Uncertainty
Haplorhini
Blood Vessels
Breast
Lymph Nodes
Breast Neoplasms
Skin
Surveys and Questionnaires

Keywords

  • Breast cancer
  • Breast reconstruction
  • Post-mastectomy radiotherapy
  • Survey

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

The Assisi Think Tank Meeting and Survey of post MAstectomy Radiation Therapy after breast reconstruction : The ATTM-SMART report. / Aristei, Cynthia; Kaidar-Person, Orit; Tagliaferri, Luca; Arenas, Meritxell; Coles, Charlotte E.; Offersen, Birgitte V.; Frezza, Giovanni; Leonardi, Maria Cristina; Valentini, Vincenzo; Bourgier, Céline; Poortmans, Philip M.P.

In: European Journal of Surgical Oncology, Vol. 44, No. 4, 01.04.2018, p. 436-443.

Research output: Contribution to journalArticle

Aristei, C, Kaidar-Person, O, Tagliaferri, L, Arenas, M, Coles, CE, Offersen, BV, Frezza, G, Leonardi, MC, Valentini, V, Bourgier, C & Poortmans, PMP 2018, 'The Assisi Think Tank Meeting and Survey of post MAstectomy Radiation Therapy after breast reconstruction: The ATTM-SMART report', European Journal of Surgical Oncology, vol. 44, no. 4, pp. 436-443. https://doi.org/10.1016/j.ejso.2018.01.010
Aristei, Cynthia ; Kaidar-Person, Orit ; Tagliaferri, Luca ; Arenas, Meritxell ; Coles, Charlotte E. ; Offersen, Birgitte V. ; Frezza, Giovanni ; Leonardi, Maria Cristina ; Valentini, Vincenzo ; Bourgier, Céline ; Poortmans, Philip M.P. / The Assisi Think Tank Meeting and Survey of post MAstectomy Radiation Therapy after breast reconstruction : The ATTM-SMART report. In: European Journal of Surgical Oncology. 2018 ; Vol. 44, No. 4. pp. 436-443.
@article{80a719e547174cb7878f2e25599641aa,
title = "The Assisi Think Tank Meeting and Survey of post MAstectomy Radiation Therapy after breast reconstruction: The ATTM-SMART report",
abstract = "Purpose: To describe the current European practise on post-mastectomy radiation therapy (PMRT) in relation to breast reconstruction. Methods: A 21-item questionnaire was distributed online via Survey Monkey. Items referred to 1. general topics (country, centre, years of experience in breast cancer); 2. clinical decision making; 3. RT techniques and dosimetry; 4. dose fractionation. Results: 283 responses were received from 19 countries. Most responders worked in public health services and in academic institutions and had 5–20 years experience. Although many indicated they were consulted about the timing and type of breast reconstructive surgery, final decisions were most often made by surgeons. Immediate reconstruction with expander followed by RT and subsequently permanent reconstruction with prosthesis was recommended by 61.6{\%} of responders. Most (48.4{\%}) adviced a boost only when margins were close or involved with an another 17.7{\%} recommending it in the presence of high-risk features (T3-T4, lympho-vascular involvement). Intensity modulated RT was rarely used by about two-thirds of responders, except when with 3D technique the dose constraints were not achieved or when regional lymph nodes were included. Almost 60{\%} of responders did not use bolus/tissue equivalent material (TEM). The main indication for bolus/TEM use was skin involvement. The majority of responders used 1.8–2 Gy per fraction. Conclusions: The present survey highlighted controversial areas in clinical practise, confirming the uncertainties about the scheduling of PMRT and breast reconstruction.",
keywords = "Breast cancer, Breast reconstruction, Post-mastectomy radiotherapy, Survey",
author = "Cynthia Aristei and Orit Kaidar-Person and Luca Tagliaferri and Meritxell Arenas and Coles, {Charlotte E.} and Offersen, {Birgitte V.} and Giovanni Frezza and Leonardi, {Maria Cristina} and Vincenzo Valentini and C{\'e}line Bourgier and Poortmans, {Philip M.P.}",
year = "2018",
month = "4",
day = "1",
doi = "10.1016/j.ejso.2018.01.010",
language = "English",
volume = "44",
pages = "436--443",
journal = "European Journal of Surgical Oncology",
issn = "0748-7983",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - The Assisi Think Tank Meeting and Survey of post MAstectomy Radiation Therapy after breast reconstruction

T2 - The ATTM-SMART report

AU - Aristei, Cynthia

AU - Kaidar-Person, Orit

AU - Tagliaferri, Luca

AU - Arenas, Meritxell

AU - Coles, Charlotte E.

AU - Offersen, Birgitte V.

AU - Frezza, Giovanni

AU - Leonardi, Maria Cristina

AU - Valentini, Vincenzo

AU - Bourgier, Céline

AU - Poortmans, Philip M.P.

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Purpose: To describe the current European practise on post-mastectomy radiation therapy (PMRT) in relation to breast reconstruction. Methods: A 21-item questionnaire was distributed online via Survey Monkey. Items referred to 1. general topics (country, centre, years of experience in breast cancer); 2. clinical decision making; 3. RT techniques and dosimetry; 4. dose fractionation. Results: 283 responses were received from 19 countries. Most responders worked in public health services and in academic institutions and had 5–20 years experience. Although many indicated they were consulted about the timing and type of breast reconstructive surgery, final decisions were most often made by surgeons. Immediate reconstruction with expander followed by RT and subsequently permanent reconstruction with prosthesis was recommended by 61.6% of responders. Most (48.4%) adviced a boost only when margins were close or involved with an another 17.7% recommending it in the presence of high-risk features (T3-T4, lympho-vascular involvement). Intensity modulated RT was rarely used by about two-thirds of responders, except when with 3D technique the dose constraints were not achieved or when regional lymph nodes were included. Almost 60% of responders did not use bolus/tissue equivalent material (TEM). The main indication for bolus/TEM use was skin involvement. The majority of responders used 1.8–2 Gy per fraction. Conclusions: The present survey highlighted controversial areas in clinical practise, confirming the uncertainties about the scheduling of PMRT and breast reconstruction.

AB - Purpose: To describe the current European practise on post-mastectomy radiation therapy (PMRT) in relation to breast reconstruction. Methods: A 21-item questionnaire was distributed online via Survey Monkey. Items referred to 1. general topics (country, centre, years of experience in breast cancer); 2. clinical decision making; 3. RT techniques and dosimetry; 4. dose fractionation. Results: 283 responses were received from 19 countries. Most responders worked in public health services and in academic institutions and had 5–20 years experience. Although many indicated they were consulted about the timing and type of breast reconstructive surgery, final decisions were most often made by surgeons. Immediate reconstruction with expander followed by RT and subsequently permanent reconstruction with prosthesis was recommended by 61.6% of responders. Most (48.4%) adviced a boost only when margins were close or involved with an another 17.7% recommending it in the presence of high-risk features (T3-T4, lympho-vascular involvement). Intensity modulated RT was rarely used by about two-thirds of responders, except when with 3D technique the dose constraints were not achieved or when regional lymph nodes were included. Almost 60% of responders did not use bolus/tissue equivalent material (TEM). The main indication for bolus/TEM use was skin involvement. The majority of responders used 1.8–2 Gy per fraction. Conclusions: The present survey highlighted controversial areas in clinical practise, confirming the uncertainties about the scheduling of PMRT and breast reconstruction.

KW - Breast cancer

KW - Breast reconstruction

KW - Post-mastectomy radiotherapy

KW - Survey

UR - http://www.scopus.com/inward/record.url?scp=85044103283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044103283&partnerID=8YFLogxK

U2 - 10.1016/j.ejso.2018.01.010

DO - 10.1016/j.ejso.2018.01.010

M3 - Article

C2 - 29422254

AN - SCOPUS:85044103283

VL - 44

SP - 436

EP - 443

JO - European Journal of Surgical Oncology

JF - European Journal of Surgical Oncology

SN - 0748-7983

IS - 4

ER -